MyHealthcare and AliveCor bring heart health in the hands of Indians

Our Bureau

MyHealthcare and AliveCor have teamed up to allow patients to be able to read their ECG data directly from their KardiaMobile 6L device into the MyHealthcare platform. The FDA-cleared KardiaMobile device is the most clinically validated personal ECG solution in the world and the partnership will aim to help patients monitor their heart health at the comfort of their home. The association is a steppingstone in bringing to the market an integrated cardiac care programme.

Owing to the accessibility challenges to quality healthcare in the country and COVID related infection fears, the portable and technology-enabled ECG device will help deliver affordable and convenient heart care to over 250 million people at risk of heart disease, without visiting a hospital.  Technology like this gives patients the ability to take control of their own heart health and play a more active role in their care management.

The data generated through the ECG device can be seen on the MyHealthcare app and seamlessly flows into the MyHealthcare EMR for doctors and caregivers, monitoring their patient’s health records. The partnership will also bring to MyHealthcare patients integrated cardiac care programmes, which will allow patients to sign up through the MyHealthcare partner hospitals onto a care plan, which monitors their cardiac function, any outlier data and deliver alerts to the care team when needed and seek consult with cardiologists from MyHealthcare partner hospitals. The MyHealthcare care programmes aim to work with remote monitoring device companies such as AliveCor to build long term care monitoring and helps build a longitudinal patient history.

Lokesh Prasad, Managing Director, AliveCor India commented, “Our commitment to India is further reinforced by the partnership with MyHealthcare in bringing an integrated platform, where patients can use the MyHealthcare platform to monitor their ECG. KardiaMobile serves a critical function in the need for remote patient management in India. Our devices use machine learning to detect arrhythmias quickly and efficiently with 98% sensitivity and 97% specificity. This gives patients and physicians fast and highly reliable data that can be easily used to influence a care plan.  Through our association with MyHealthcare and its partner hospitals, we hope to analyse critical heart data and build a preventive integrated care programme, which will be a first step in remote cardiac monitoring.”

Commenting on the association, Shyatto Raha, Founder and Chief Executive Officer at MyHealthcare said, “In the wake of the recent pandemic, the telemedicine industry has grown in leaps and bounds. However, the core focus currently of most platforms is to deliver a virtual consult between a patient and doctor, addressing just one part of the care needs of a patient. The true value lies in the complete care management of a patient, including health monitoring and delivering care at home, which would be as close to the care delivered in a hospital. One of the key challenges facing telemedicine today is that doctors are unable to physically assess the patient or look at their vitals. The partnership with AliveCor and the integrated clinical data delivery to the doctors via the MyHealthcare EMR will help bring the platform a step closer to the in-OPD experience.”

The association is slated to be an industry-first and would essentially mean a giant leap for the telemedicine industry in India.


Leave a Reply

Your email address will not be published. Required fields are marked *

Next Post

Novartis renews WHO medicine donation pledge with aim of ending leprosy

A renewed partnership agreement signed by Novartis and the World Health Organization (WHO) will drive the global push towards making leprosy history. The five-year extension of the partnership – which was first signed in 2000 – will see Novartis continue to donate multidrug therapy (MDT) medicines to treat leprosy up […]

Subscribe Now